Skip to main content
Erschienen in: Diabetologia 3/2004

01.03.2004 | Article

Neointimal proliferation within carotid stents is more pronounced in diabetic patients with initial poor glycaemic state

verfasst von: A. Willfort-Ehringer, R. Ahmadi, A. Gessl, M. E. Gschwandtner, A. Haumer, W. Lang, E. Minar, S. Zehetmayer, H. Ehringer

Erschienen in: Diabetologia | Ausgabe 3/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We studied the influence of initial hyperglycaemia on neointimal proliferation within carotid Wallstents.

Methods

A total of 112 patients were followed by duplex sonography after carotid stenting for 24 months. Patients were assigned to three groups: non-diabetic subjects (group A) and diabetic patients, who were assigned according to their baseline HbA1c values, to group B1(HbA1c≤6.5%) or group B2 (HbA1c>6.5%).

Results

At baseline the groups did not differ with respect to other vascular risk factors and residual stenosis on angiograms. The maximal thickness of the layer between the stent and the perfused lumen was measured at the duplex follow-ups. At 3 months the typical ultrasonic structure of the neointima was clearly discernible. From this point on, group B2 differed significantly (p<0.001) compared with B1 and A with respect to the maximal thickness of neointima and the time course of its ingrowth: group A vs B1 vs B2 was 0.51±0.39 vs 0.52±0.33 vs 0.56±0.35 at 3 months, 0.91±0.27 vs 0.90±0.38 vs 1.14±0.48 at 6 months, 1.02±0.24 vs 0.97±0.34 vs 1.21±0.44 at 12 months and 1.09±0.23 vs 1.10±0.31 vs 1.23±0.37 at 24 months.

Conclusion/interpretation

Initial hyperglycaemia seems to be a predictor of more pronounced neointimal proliferation after carotid stenting independent of diabetes. As intimal hyperplasia is known to be responsible for stent restenosis, strict optimisation of the hyperglycaemic state should be aimed at before elective carotid artery stenting.
Literatur
1.
Zurück zum Zitat Theron JG, Payelle GG, Coskun O et al. (1996) Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement. Radiology 201:627–636CrossRefPubMed Theron JG, Payelle GG, Coskun O et al. (1996) Carotid artery stenosis: treatment with protected balloon angioplasty and stent placement. Radiology 201:627–636CrossRefPubMed
2.
Zurück zum Zitat New G, Roubin GS, Iyer SS et al. (1999) Carotid artery stenting: rationale, indications, and results. Compr Ther 25:438–445CrossRefPubMed New G, Roubin GS, Iyer SS et al. (1999) Carotid artery stenting: rationale, indications, and results. Compr Ther 25:438–445CrossRefPubMed
3.
Zurück zum Zitat Wholey MH, Jarmolowski CR, Wholey M et al. (2003) Carotid artery stent placement-ready for prime time? J Vasc Interv Radiol 14:1–10CrossRefPubMed Wholey MH, Jarmolowski CR, Wholey M et al. (2003) Carotid artery stent placement-ready for prime time? J Vasc Interv Radiol 14:1–10CrossRefPubMed
4.
Zurück zum Zitat Yadav JS, Roubin GS, Iyer S et al. (1997) Elective stenting of the extracranial carotid arteries. Circulation 95:376–381CrossRefPubMed Yadav JS, Roubin GS, Iyer S et al. (1997) Elective stenting of the extracranial carotid arteries. Circulation 95:376–381CrossRefPubMed
5.
Zurück zum Zitat Dangas G, Laird JR, Mehran R et al. (2001) Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy. J Endovasc Ther 8:39–43CrossRefPubMed Dangas G, Laird JR, Mehran R et al. (2001) Carotid artery stenting in patients with high-risk anatomy for carotid endarterectomy. J Endovasc Ther 8:39–43CrossRefPubMed
6.
Zurück zum Zitat Ahmadi A, Willfort A, Lang et al. (2001) Carotid artery stenting: effect of learning curve and intermediate-term morphological outcome. J Endovasc Ther 8:539–546CrossRefPubMed Ahmadi A, Willfort A, Lang et al. (2001) Carotid artery stenting: effect of learning curve and intermediate-term morphological outcome. J Endovasc Ther 8:539–546CrossRefPubMed
7.
Zurück zum Zitat Wholey MH, Wholey M, Mathias K et al. (2000) Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 50:160–167CrossRefPubMed Wholey MH, Wholey M, Mathias K et al. (2000) Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 50:160–167CrossRefPubMed
8.
Zurück zum Zitat CAVATAS Investigators (2001) Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 357:1729–1737CrossRef CAVATAS Investigators (2001) Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 357:1729–1737CrossRef
9.
Zurück zum Zitat Salonen JT, Salonen R (1993) Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 87:II56–II65PubMed Salonen JT, Salonen R (1993) Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 87:II56–II65PubMed
10.
Zurück zum Zitat De Bray JM, Glatt B, for the International Consensus Conference P, December 1994 (1995) Quantification of atheromatous stenosis in the extracranial internal carotid artery. Cerebrovasc Dis 5:414–426CrossRef De Bray JM, Glatt B, for the International Consensus Conference P, December 1994 (1995) Quantification of atheromatous stenosis in the extracranial internal carotid artery. Cerebrovasc Dis 5:414–426CrossRef
11.
Zurück zum Zitat Robbin ML, Lockhart ME, Weber TM et al. (1997) Carotid artery stents: early and intermediate follow-up with Doppler US. Radiology 205:749–756CrossRefPubMed Robbin ML, Lockhart ME, Weber TM et al. (1997) Carotid artery stents: early and intermediate follow-up with Doppler US. Radiology 205:749–756CrossRefPubMed
12.
Zurück zum Zitat Willfort-Ehringer A, Ahmadi A, Gschwandtner M et al. (2003) Healing of carotid stents: a prospective duplex ultrasound study. J Endovasc Ther 10:636–642CrossRefPubMed Willfort-Ehringer A, Ahmadi A, Gschwandtner M et al. (2003) Healing of carotid stents: a prospective duplex ultrasound study. J Endovasc Ther 10:636–642CrossRefPubMed
13.
Zurück zum Zitat Willfort-Ehringer A, Ahmadi A, Gschwandtner M et al. (2002) Single-center experience with carotid stent restenosis. J Endovasc Ther 9:299–307CrossRefPubMed Willfort-Ehringer A, Ahmadi A, Gschwandtner M et al. (2002) Single-center experience with carotid stent restenosis. J Endovasc Ther 9:299–307CrossRefPubMed
14.
Zurück zum Zitat Heiss G, Sharrett R, Barnes RW et al. (1991) Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol134:250–256 Heiss G, Sharrett R, Barnes RW et al. (1991) Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol134:250–256
15.
Zurück zum Zitat Kanters S, Banga J, Stolk R et al. (1999) Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis. Vasc Med 4:67–75CrossRefPubMed Kanters S, Banga J, Stolk R et al. (1999) Incidence and determinants of mortality and cardiovascular events in diabetes mellitus: a meta-analysis. Vasc Med 4:67–75CrossRefPubMed
16.
Zurück zum Zitat Gu K, Cowie C, Harris M (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291–1297CrossRefPubMed Gu K, Cowie C, Harris M (1999) Diabetes and decline in heart disease mortality in US adults. JAMA 281:1291–1297CrossRefPubMed
17.
Zurück zum Zitat Khaw K, Wareham N, Luben R et al. (2001) Glycated haemoglobin, diabetes and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322:15–18CrossRefPubMedPubMedCentral Khaw K, Wareham N, Luben R et al. (2001) Glycated haemoglobin, diabetes and mortality in men in Norfolk cohort of european prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 322:15–18CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Moss S, Klein R, Klein B et al. (1994) The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 154:2473–2479CrossRefPubMed Moss S, Klein R, Klein B et al. (1994) The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med 154:2473–2479CrossRefPubMed
19.
Zurück zum Zitat Avignon A, Radauceanu A, Monnier L (1997) Nonfasting glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822–1826CrossRefPubMed Avignon A, Radauceanu A, Monnier L (1997) Nonfasting glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822–1826CrossRefPubMed
20.
Zurück zum Zitat Gaede P, Vedel P, Parving HH et al. (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353:617–22CrossRefPubMed Gaede P, Vedel P, Parving HH et al. (1999) Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353:617–22CrossRefPubMed
21.
Zurück zum Zitat UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–53CrossRef UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–53CrossRef
22.
Zurück zum Zitat Alberti, Zimmet (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553CrossRef Alberti, Zimmet (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553CrossRef
23.
Zurück zum Zitat Fowkes F, Housley E, Cawood E et al. (1991) Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20:384–392CrossRefPubMed Fowkes F, Housley E, Cawood E et al. (1991) Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20:384–392CrossRefPubMed
24.
Zurück zum Zitat North American Symptomatic Endarterectomy Trial Collaborators (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 325:445–453CrossRef North American Symptomatic Endarterectomy Trial Collaborators (1991) Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade stenosis. N Engl J Med 325:445–453CrossRef
25.
Zurück zum Zitat Nicolaides AN, Shifrin EG, Bradbury A et al. (1996) Angiographic and duplex grading of internal carotid stenosis: can we overcome the confusion? J Endovasc Surg 3:158–165CrossRefPubMed Nicolaides AN, Shifrin EG, Bradbury A et al. (1996) Angiographic and duplex grading of internal carotid stenosis: can we overcome the confusion? J Endovasc Surg 3:158–165CrossRefPubMed
26.
Zurück zum Zitat Geroulakos G, Ramaswami G, Veller M et al. (1994) Arterial wall changes in type 2 diabetic subjects. Diabet Med 11:692–695CrossRefPubMed Geroulakos G, Ramaswami G, Veller M et al. (1994) Arterial wall changes in type 2 diabetic subjects. Diabet Med 11:692–695CrossRefPubMed
27.
Zurück zum Zitat Niskanen L, Rauramaa R, Miettinen H et al. (1996) Carotid artery intima-media thickness in elderly patients with NIDDM and in non diabetic subjects. Stroke 27:1986–1992CrossRefPubMed Niskanen L, Rauramaa R, Miettinen H et al. (1996) Carotid artery intima-media thickness in elderly patients with NIDDM and in non diabetic subjects. Stroke 27:1986–1992CrossRefPubMed
28.
Zurück zum Zitat Yamasaki Y, Kodama M, Nishizawa H et al. (2000) Carotid intima-media thickness in Japanese type 2 diabetic subjects. Diabetes Care 23:1310–1315CrossRefPubMed Yamasaki Y, Kodama M, Nishizawa H et al. (2000) Carotid intima-media thickness in Japanese type 2 diabetic subjects. Diabetes Care 23:1310–1315CrossRefPubMed
29.
Zurück zum Zitat Gerstein H, Anand S, Long Yi Q et al. for The SHARE Investigators (2003) The relationship between dysglycemia and atherosclerosis in south asian, chinese, and european individuals in canada. Diabetes Care 26:144–149CrossRefPubMed Gerstein H, Anand S, Long Yi Q et al. for The SHARE Investigators (2003) The relationship between dysglycemia and atherosclerosis in south asian, chinese, and european individuals in canada. Diabetes Care 26:144–149CrossRefPubMed
30.
Zurück zum Zitat Furberg C, Adams H, Applegate W (1994) Effect of lovastatin on early carotid artherosclerosis and cardiovascular events. Circulation 90:1679–1687CrossRefPubMed Furberg C, Adams H, Applegate W (1994) Effect of lovastatin on early carotid artherosclerosis and cardiovascular events. Circulation 90:1679–1687CrossRefPubMed
31.
Zurück zum Zitat Salonen R, Nyyssonen K, Porkkala E (1995) Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 92:1758–1764CrossRefPubMed Salonen R, Nyyssonen K, Porkkala E (1995) Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 92:1758–1764CrossRefPubMed
32.
Zurück zum Zitat Kastelein JP, Wiegman A, Groot E (2003) Surrogate markers of atherosclerosis: impact of statins. Atherosclerosis [Suppl] 4:31–36 Kastelein JP, Wiegman A, Groot E (2003) Surrogate markers of atherosclerosis: impact of statins. Atherosclerosis [Suppl] 4:31–36
33.
Zurück zum Zitat Komada M, Yamasaki Y, Sakamoto K et al. (2000) Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Thromb Res 15:239–245 Komada M, Yamasaki Y, Sakamoto K et al. (2000) Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Thromb Res 15:239–245
34.
Zurück zum Zitat Stratton I, Adler A, Neil H et al. (2000) Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321:405–412CrossRefPubMedPubMedCentral Stratton I, Adler A, Neil H et al. (2000) Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321:405–412CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosilation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315–1321CrossRefPubMed Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosilation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315–1321CrossRefPubMed
36.
Zurück zum Zitat Schillinger M, Exner M, Amighi J et al. (2003) Joint effects of C-reactive protein and glycated hemoglobin predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation 108:2323–1328CrossRefPubMed Schillinger M, Exner M, Amighi J et al. (2003) Joint effects of C-reactive protein and glycated hemoglobin predicting future cardiovascular events of patients with advanced atherosclerosis. Circulation 108:2323–1328CrossRefPubMed
Metadaten
Titel
Neointimal proliferation within carotid stents is more pronounced in diabetic patients with initial poor glycaemic state
verfasst von
A. Willfort-Ehringer
R. Ahmadi
A. Gessl
M. E. Gschwandtner
A. Haumer
W. Lang
E. Minar
S. Zehetmayer
H. Ehringer
Publikationsdatum
01.03.2004
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 3/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1345-3

Weitere Artikel der Ausgabe 3/2004

Diabetologia 3/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

VHF-Ablation nützt wohl nur bei reduzierter Auswurfleistung

02.05.2024 Ablationstherapie Nachrichten

Ob die Katheterablation von Vorhofflimmern bei Patienten mit Herzinsuffizienz die Komplikationsraten senkt, scheint davon abzuhängen, ob die Auswurfleistung erhalten ist oder nicht. Das legen die Ergebnisse einer Metaanalyse nahe.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.